News

November 20, 2018

SWE-Life for EIC pilot grant

Medvasc AB has been granted funding from SWE-Life 100.000 SEK for the project “Solutio-Improved varicose vein surgery via new medical device “in the framework of the EIC pilot grant preparation Horizon2020, SME instruments phase 2 Read more about the grant: https://swelife.se/projekt/stod-for-att-soka-eic-pilot/…
September 3, 2018

Successful animal studies

During the past months Medvasc has conducted a successful studies on living sheep and pigs in Haifa, Israel. The Studies was conducted in a controlled manner in an operating environment and intended to investigate Solutios usability and function, both of which could be met….
November 14, 2017

MedTech4Health grant

Medvasc AB has been granted funding 2M SEK supporting the project “Solutio-Improved varicose vein surgery via new medical device Instrument” within the framework of MedTech4Health medical device twinning 2017. The funding spans two years. Read more: https://medtech4health.se/tag/medvasc/ Read more: https://www.vinnova.se/p/solutio-forbattrad-aderbrackskirurgi-via-nytt-medicintekniskt-instrument/…
September 6, 2017

Nordic Life Science Days 12-14 September

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in…
August 15, 2017

LU Holding investerar i åderbråcksbehandling

I bolaget MedVasc har Lundaforskaren Michael Åkesson placerat rättigheterna till ett medicintekniskt instrument som ska göra laserbehandling av åderbråck mindre smärtsam. Nu går affärsutvecklaren Jörgen Gustafsson in som vd och delägare tillsammans med universitetets såddfinansieringsbolag LU Holding.  Michael Åkessons instrument är ett komplement till laserfiber som redan används för…

For press inquiries, please send an email

Subscribe to our newsletter

For more information on how we process your personal data please see our Privacy Notice